Medline to report fourth quarter and full year 2025 results on February 25, 2026
MDLNNORTHFIELD, Ill., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report fourth quarter and full year 2025 financial results on Wednesday, February 25, 2026. A press release and supplemental materials will be issued before the market opens. The company will host a webcast and conference call at 9:30am ET/ 8:30am CT to discuss the financial results.
Medline Announces Pricing of Upsized Initial Public Offering
MDLNNORTHFIELD, Ill., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) announced today the pricing of its upsized initial public offering of 216,034,482 shares of its Class A common stock, at a public offering price of $29.00 per share. Medline has granted the underwriters a 30-day option to purchase up to an additional 32,405,172 shares of Class A common stock. The shares are expected to begin trading on the Nasdaq Global Select Market on December 17, 2025, under the symbol “MDLN.”
Avante Group names Medline its Prime Vendor
MDLNMedline providing operational and clinical solutions to Florida-based skilled nursing provider NORTHFIELD, Ill., June 18, 2025 /PRNewswire/ -- Medline today announced a new Prime Vendor agreement with Florida-based skilled nursing and rehabilitative services provider Avante Group. As part...
